JBJ Investment Partners’s GSK GSK Stock Holding History

JBJ Investment Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-349	Closed	-$18K	–	113
2019 Q1	$18K	Buy	+349	New	+$17.4K	0.01%	153

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

JBJ Investment Partners's GSK Position: Q2 2019 in Review

JBJ Investment Partners sold out of GSK (GSK) in Q2 2019, closing a stake of 349 shares — an estimated $18K sold.

JBJ Investment Partners first reported a position in GSK in Q1 2019 and held it in 1 quarter. The position peaked at $18K in Q1 2019. 804 funds tracked by Wall St. Rank hold GSK as of Q2 2019.

JBJ Investment Partners reported no remaining GSK position as of Q2 2019 after selling out during the quarter.
JBJ Investment Partners sold 349 GSK shares in Q2 2019, an estimated $18K.
JBJ Investment Partners first reported a position in GSK in Q1 2019 and held it in 1 quarter.
JBJ Investment Partners's GSK position peaked at $18K in Q1 2019.
804 funds tracked by Wall St. Rank held GSK as of Q2 2019.

Based on JBJ Investment Partners's 13F filing for Q2 2019, filed 25 Jul 2019.